In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

This comprehensive review analyzes cutting-edge tools and technologies in modern pharmaceutical research, focusing on ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

The ongoing conflicts between Ukraine and Russia, as well as Israel and Palestine, have sent ripples across various ...

Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs ...

Dr. Dina Radenkovic, CEO of Gameto, identifies strategies to close the gap in women's health and how we can better incentivize research and development in this area.

Discover Lantern Pharma's transformative 2024 journey in precision oncology with AI breakthroughs, global trial expansions, and key clinical milestones ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

Artificial Intelligence is revolutionizing pharmaceuticals, accelerating drug discovery, and optimizing clinical trials. Yet, ...